Skip to content
IRCCS National Neurological Institute

IRCCS National Neurological Institute

This formulation of Ambroxol acts as a GCase enhancer and is designed to improve glucocerebrosidase activity to treat Parkinson's disease by slowing its progression through the same enzymatic pathway.

Cart 0

Your cart is currently empty.

Start Shopping